CD274 and neoplasm: Additionally, tumor cells recruit inhibitory immune cells like myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) to disrupt the cytotoxic capabilities of effector T cells, and express ligands associated with immune checkpoints, like programmed death ligand (PD-L1/L2), that inhibit the immune response [38].